Are you Dr. Jacobson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2390 E Florida Ave
#207
Hemet, CA 92544Phone+1 951-652-6100Fax+1 951-658-7548
Summary
- Dr. Arthur Jacobson, MD is a board certified ophthalmologist in Hemet, California. He is currently licensed to practice medicine in California, Texas, and Tennessee. He is affiliated with Hemet Global Medical Center, Menifee Global Medical Center, and Loma Linda University Medical Center-Murrieta.
Education & Training
- Michael Reese Hospital and Medical CenterResidency, Ophthalmology, 1978 - 1980
- Good Samaritan HospitalInternship, Internal Medicine, 1976 - 1977
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1976
Certifications & Licensure
- CA State Medical License 1977 - 2025
- TX State Medical License 1995 - 2002
- TN State Medical License 1992 - 1997
- IL State Medical License 1977 - 1984
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Publications & Presentations
PubMed
- 34 citationsHeroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.Oscar B. Torres, Gary R. Matyas, Mangala Rao, Kristina K. Peachman, Rashmi Jalah
NPJ Vaccines. 2017-05-02 - 17 citationsA simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse.Oscar B. Torres, Joshua F. G. Antoline, Fuying Li, Rashmi Jalah, Arthur E. Jacobson
Analytical and Bioanalytical Chemistry. 2016-02-01 - 15 citationsChiral Resolution and Absolute Configuration of the Enantiomers of the Psychoactive “Designer Drug” 3,4‐MethylenedioxypyrovaleroneMasaki Suzuki, Jeffrey R. Deschamps, Arthur E. Jacobson, Kenner C. Rice
Chirality. 2015-04-01
Professional Memberships
- Fellow